MOH — authorised 26 June 1997
- Marketing authorisation holder: MCNEIL
- Status: likely_approved
🇮🇱 Imodium Multi-Symptom Relief in Israel
MOH authorised Imodium Multi-Symptom Relief on 26 June 1997
Marketing authorisation
Imodium Multi-Symptom Relief in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Dermatology approved in Israel
Frequently asked questions
Is Imodium Multi-Symptom Relief approved in Israel?
Yes. MOH authorised it on 26 June 1997.
Who is the marketing authorisation holder for Imodium Multi-Symptom Relief in Israel?
MCNEIL holds the Israeli marketing authorisation.